Cardiac resynchronization therapy in mild heart failure: a review of the REVERSE and MADIT-CRT trials.

Abstract:

:Cardiac resynchronization therapy has become part of the treatment strategy for advanced, symptomatic heart failure, but newly published trials show that more patients than previously realized may benefit from this therapy, including those with mild heart failure symptoms. The REVERSE and MADIT-CRT trials showed that cardiac resynchronization therapy reduces risk of hospitalization for heart failure and leads to beneficial reverse remodeling of the left ventricle in mild heart failure, especially in patients with prolonged QRS complexes. Ongoing studies aim to expand the indications for this therapy even further, including in patients with normal ejection fractions and a need for frequent ventricular pacing. The current body of evidence favors cardiac resynchronization therapy in patients with a depressed ejection fraction and prolonged QRS, even with minimal or no heart failure symptoms.

journal_name

Curr Cardiol Rep

authors

Reynolds CR,Gold MR

doi

10.1007/s11886-010-0125-6

subject

Has Abstract

pub_date

2010-09-01 00:00:00

pages

367-73

issue

5

eissn

1523-3782

issn

1534-3170

journal_volume

12

pub_type

杂志文章,评审
  • Management of hemorrhagic stroke.

    abstract::Fifty thousand Americans suffer an intracerebral hemorrhage (ICH) annually, one third of whom die as a result. Poorly controlled hypertension is the most important risk factor for ICH. Over time it results in pathologic changes to small intracranial vessels, leading to their rupture. All stroke patients, including tho...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-002-0029-1

    authors: Tuhrim S

    更新日期:2002-03-01 00:00:00

  • Emerging inflammatory markers for assessing coronary heart disease risk.

    abstract::Although assessment of traditional coronary heart disease risk factors can often stratify individuals into low- or high-risk categories, additional means are needed to more precisely classify people clinically defined as intermediate-risk, to guide the intensity of risk-reducing therapies. The recognition that inflamm...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-009-0065-1

    authors: Corson MA

    更新日期:2009-11-01 00:00:00

  • Sudden cardiac death without structural heart disease: update on the long QT and Brugada syndromes.

    abstract::The long QT syndrome (LQTS) and the Brugada syndrome (BrS) are the most common genetic causes of malignant ventricular arrhythmias and sudden cardiac death in young patients with normal cardiac morphology. To date, more than 250 different mutations in seven genes have been identified as causing LQTS, whereas the only ...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-005-0088-1

    authors: Goldenberg I,Moss AJ,Zareba W

    更新日期:2005-09-01 00:00:00

  • Evidence relating sodium intake to blood pressure and CVD.

    abstract::Sodium is an essential nutrient, mostly ingested as salt (sodium chloride). Average sodium intake ranges from 3 to 6 g per day (7.5-15 g/day of salt) in most countries, with regional variations. Increasing levels of sodium intake have a positive association with higher blood pressure. Randomized controlled trials repo...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-014-0529-9

    authors: O'Donnell M,Mente A,Yusuf S

    更新日期:2014-01-01 00:00:00

  • Telestroke.

    abstract:PURPOSE OF REVIEW:This study aims to describe the current state of telestroke clinical applications and policies, in addition to key technical and operational aspects of the telemedicine practice. RECENT FINDINGS:Delivery of telestroke services for neurovascular care expanded from the intravenous alteplase decision an...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-017-0895-1

    authors: Dumitrascu OM,Demaerschalk BM

    更新日期:2017-09-01 00:00:00

  • What is the role of aldosterone excess in resistant hypertension and how should it be investigated and treated?

    abstract::Resistant hypertension has evolved as an important global health care problem. Primary aldosteronism is one of several potentially reversible causes of resistant hypertension. Primary aldosteronism can be effectively treated, when recognized, with a mineralocorticoid receptor antagonist, such as spironolactone and epl...

    journal_title:Current cardiology reports

    pub_type: 杂志文章

    doi:10.1007/s11886-011-0224-z

    authors: Sica DA

    更新日期:2011-12-01 00:00:00

  • Transcatheter aortic valve replacement: an update.

    abstract::Aortic stenosis affects many people worldwide with a significant impact on morbidity and mortality with uncorrected, symptomatic aortic valve stenosis carrying mortality of 50% at one year. Degenerative calcific pathology, the most common cause of aortic stenosis, increases in prevalence with age; estimated prevalence...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-013-0367-1

    authors: Halim SA,Kiefer TL,Hughes GC,Hurwitz LM,Harrison JK

    更新日期:2013-06-01 00:00:00

  • Diastolic function in hypertension.

    abstract::Diastolic dysfunction in patients with hypertension may present as asymptomatic findings on noninvasive testing, or as fulminant pulmonary edema, despite normal left ventricular systolic function. Up to 40% of hypertensive patients presenting with clinical signs of congestive heart failure have normal systolic left ve...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-001-0071-4

    authors: Phillips RA,Diamond JA

    更新日期:2001-11-01 00:00:00

  • The Role of Manual Aspiration Thrombectomy in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI.

    abstract::In STEMI, primary PCI restores macrovascular coronary blood flow effectively but microvascular perfusion remains a challenge. Thrombus has the potential to embolize to the microvasculature limiting effective coronary blood flow. Thrombus burden is associated with a higher mortality and manual aspiration thrombectomy h...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-016-0707-z

    authors: Alak A,Jolly SS

    更新日期:2016-03-01 00:00:00

  • Safety and efficacy of nesiritide for acute decompensated heart failure: recent literature and upcoming trials.

    abstract::Congestive heart failure is increasing in prevalence in the United States, and associated morbidity and mortality remain high. Aggressive treatment of decompensated heart failure is associated with improved outcomes; however, therapies must be tailored to the presenting characteristics of each patient and most carry a...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/BF02938348

    authors: Hiestand B,Abraham WT

    更新日期:2007-05-01 00:00:00

  • PCSK9 Inhibitors: Treating the Right Patients in Daily Practice.

    abstract:PURPOSE OF REVIEW:Monoclonal antibodies that inhibit proprotein convertase subtilisin/kexin type 9 (PCSK9) have emerged as a novel approach to low-density lipoprotein cholesterol (LDL-C) lowering. The potential role of PCSK9 inhibitors in clinical practice will be reviewed. RECENT FINDINGS:Clinical trials have demonst...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-017-0882-6

    authors: King P,Nicholls SJ

    更新日期:2017-08-01 00:00:00

  • The selection of antithrombotic agents in the prevention of recurrent ischemic stroke.

    abstract::The scientific selection of antithrombotic therapy has been dominated by group-based interpretation of data in the form of probability-based statistics in evidence-based medicine. Because the data in large randomized trials are grouped and averaged, the relationship to initial conditions of the patient is lost. There ...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-003-0083-3

    authors: Helgason CM

    更新日期:2003-03-01 00:00:00

  • Genetic Risk Factors for Ischemic and Hemorrhagic Stroke.

    abstract::Understanding the genetic risk factors for stroke is an essential step to decipher the underlying mechanisms, facilitate the identification of novel therapeutic targets, and optimize the design of prevention strategies. A very small proportion of strokes are attributable to monogenic conditions, the vast majority bein...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-016-0804-z

    authors: Chauhan G,Debette S

    更新日期:2016-12-01 00:00:00

  • Transradial versus transfemoral approach for percutaneous coronary procedures.

    abstract::Selective coronary angiography was originally performed through open brachial arteriotomy. Thereafter, the percutaneous Seldinger technique and the use of preformed Judkins-type catheters popularized the femoral approach. More recently, after the first report of successful coronary angiography by the transradial appro...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-009-0054-4

    authors: Franchi E,Marino P,Biondi-Zoccai GG,De Luca G,Vassanelli C,Agostoni P

    更新日期:2009-09-01 00:00:00

  • Overview of the US FDA medical device approval process.

    abstract::Increasing barriers to medical device innovation in the United States including constrained financial resources and rising research costs require that physicians take on greater involvement in medical device development, evaluation, and regulatory processes. Such involvement requires that physicians understand basic a...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-014-0494-3

    authors: Sastry A

    更新日期:2014-01-01 00:00:00

  • Fibrinolytic function and coronary risk.

    abstract::Plasminogen activation potential in the blood is controlled by an equilibrium between plasminogen activators, mainly tissue-type plasminogen activator (t-PA), and inhibitors, mainly plasminogen activator inhibitor (PAI)-1. In cardiovascular practice, imbalance of this fibrinolytic potential is encountered primarily in...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-999-0069-x

    authors: Juhan-Vague I,Morange P,Christine Alessi M

    更新日期:1999-07-01 00:00:00

  • Estrogen therapies, lipids, and the heart disease prevention controversy.

    abstract::One of the most highly unexpected reports in recent medical literature was the lack of benefit of estrogen-progestin replacement therapy in cardiovascular disease prevention in postmenopausal women. The ensuing negative view of hormone replacement therapy has now extended to all forms of postmenopausal hormone treatme...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-003-0110-4

    authors: Knopp RH,Aikawa K,Knopp EA

    更新日期:2003-11-01 00:00:00

  • What have we learned about plaque rupture in acute coronary syndromes?

    abstract::The most common cause of acute coronary syndrome (ACS) is rupture of an atherosclerotic lesion containing a large necrotic core and a thin fibrous cap followed by acute luminal thrombosis because the rupture of the thin fibrous cap allows contact of the platelets with the highly thrombogenic necrotic core. Pathologic ...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-010-0113-x

    authors: Choi SY,Mintz GS

    更新日期:2010-07-01 00:00:00

  • Management of Lipid Abnormalities in Patients with Diabetes.

    abstract:PURPOSE OF REVIEW:To describe lipid abnormalities in diabetes, when they occur and the evidence base for lipid management with established and new drugs to prevent diabetes complications. We also discuss how to manage statin intolerance. RECENT FINDINGS:Statins remain first-line therapy in patients with diabetes, thou...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-019-1246-1

    authors: Sillars A,Sattar N

    更新日期:2019-11-22 00:00:00

  • Heart Transplantation and Mechanical Circulatory Support in Adults with Congenital Heart Disease.

    abstract:PURPOSE OF REVIEW:To assess current management strategies for advanced heart failure in adults with congenital heart disease, including heart transplantation and mechanical circulatory support. RECENT FINDINGS:Current data demonstrate that adults with CHD generally experience higher short-term mortality after heart tr...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-018-1028-1

    authors: Serfas JD,Patel PA,Krasuski RA

    更新日期:2018-08-09 00:00:00

  • Interventional echocardiography in structural heart disease.

    abstract::Over the past decade, catheter based treatments of an increasing variety of cardiac diseases have expanded dramatically. These advancements became available through new developments and improvements in available devices, as well as increasing expertise of operators. However, arguably it is the innovation and progress ...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-012-0338-y

    authors: Perk G,Kronzon I

    更新日期:2013-03-01 00:00:00

  • Appropriateness of percutaneous coronary intervention: a review.

    abstract::The appropriateness of coronary revascularization for various clinical scenarios has been reviewed formally by several specialty and subspecialty societies resulting in the formulation of scored appropriateness criteria. The goal of the appropriateness criteria is to guide physician decision-making and future research...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-013-0379-x

    authors: Summers MR,Patel MR

    更新日期:2013-07-01 00:00:00

  • Clinical Approaches to the Patient with a Failing Fontan Procedure.

    abstract::The Fontan operation has been nothing short of revolutionary in its influence on the modern management of patients born with functionally univentricular hearts. The vast majority of these individuals are now surviving well into adulthood. In the 45 years since its introduction, however, there has been increasing recog...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-016-0716-y

    authors: Elder RW,Wu FM

    更新日期:2016-05-01 00:00:00

  • Management of Blood Pressure in Patients with Glaucoma.

    abstract:PURPOSE OF REVIEW:Ocular perfusion pressure (OPP) is defined as the difference between BP and intraocular pressure (IOP). With low BP comes low OPP and resultant ischemic damage to the optic nerve, leading to glaucoma progression. The purpose of this article is to review the literature on BP as it relates to glaucoma a...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-017-0927-x

    authors: Levine RM,Yang A,Brahma V,Martone JF

    更新日期:2017-09-19 00:00:00

  • Prognostic Biomarkers in Acute Coronary Syndromes: Risk Stratification Beyond Cardiac Troponins.

    abstract:PURPOSE OF REVIEW:Cardiac troponin (cTn) plays an essential role for assessment of outcome in acute coronary syndrome (ACS). However, the prognostic value of cTn is not absolute. In this mini-review, we summarize the evidence on the utility of established biomarkers of left-ventricular dysfunction, hemodynamic stress, ...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-017-0840-3

    authors: Eggers KM,Lindahl B

    更新日期:2017-04-01 00:00:00

  • Choosing the best contraceptive method for the adult with congenital heart disease.

    abstract::As women with congenital heart disease (CHD) approach childbearing age, issues such as pregnancy and contraception need to be addressed. Women with CHD represent a heterogeneous population. While some have simple cardiac lesions and thus have contraceptive risks that are no different from those of the general populati...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-009-0043-7

    authors: Silversides CK,Sermer M,Siu SC

    更新日期:2009-07-01 00:00:00

  • Management of Dyslipidemias in Europe and the USA: Same Evidence, Different Conclusions? Can We Find Common Ground?

    abstract:PURPOSE OF REVIEW:An examination of the current ACC/AHA and ESC/EAS Guidelines on the management of dyslipidemias for common ground and differences. RECENT FINDINGS:There is much common ground. Both note that ASCVD is, in most people, the product of a number of risk factors, notably tobacco exposure, hyperlipidemia, h...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-017-0857-7

    authors: Graham IM,Catapano AL

    更新日期:2017-06-01 00:00:00

  • Endovascular Management of Massive and Submassive Acute Pulmonary Embolism: Current Trends in Risk Stratification and Catheter-Directed Therapies.

    abstract:PURPOSE OF REVIEW:Acute pulmonary embolism (PE) is a common condition associated with high morbidity and mortality. Prior studies have evaluated the role of systemic fibrinolysis and catheter-directed therapy (CDT) in the management of PE. In this review, we examine current data on risk stratification and the appropria...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-017-0864-8

    authors: Kosova EC,Desai KR,Schimmel DR

    更新日期:2017-06-01 00:00:00

  • Correction to: Review of Transthyretin Silencers, Stabilizers, and Fibril Removal Agents in the Treatment of Transthyretin Cardiac Amyloid.

    abstract::On page 2 of the original publication, in the section on TTR Silencers dosing of patisiran in the APOLLO study was stated as being given every 3 months; this is inaccurate as patisiran was dosed every 3 weeks in the APOLLO study. ...

    journal_title:Current cardiology reports

    pub_type: 已发布勘误

    doi:10.1007/s11886-020-01426-7

    authors: Hough A,Wearden J,de Almeida K,Kaiser S

    更新日期:2020-09-28 00:00:00

  • Global risk assessment for lipid therapy to prevent coronary heart disease.

    abstract::Randomized clinical trials have established that lipid- lowering pharmacologic therapy can substantially reduce morbidity and mortality in patients with known coronary artery disease (CAD). Researchers are now working to define the role of lipid-lowering agents in the primary prevention of CAD to extend their benefit ...

    journal_title:Current cardiology reports

    pub_type: 杂志文章

    doi:10.1007/s11886-000-0056-8

    authors: Nass CM,Wiviott SD,Allen JK,Post WS,Blumenthal aR

    更新日期:2000-09-01 00:00:00